SETsquared Bristol shortlisted as Hottest Accelerator in Europe for second consecutive year

Posted by 

SETsquared Bristol

We are thrilled to be announced as a finalist of the Hottest Accelerator Award in The Europas, the premier awards for the hottest tech startups in Europe.

This is our second year in the shortlist, with 2020 seeing us winning the title against stiff competition from London and European accelerators.

This year, SETsquared Bristol is competing with four other companies, London & Partners Business Growth Programme, Outlier Ventures, SpinLab – the HHL and Startup Wise Guys. The winner will be announced at The Europas Virtual Awards on 24 June 2021.

Monika Radclyffe, SETsquared Bristol Centre Director, said: “We are delighted that we have been recognised again by a judging panel of founders and investors for our truly bespoke business support that sets us apart from other accelerators and helps our founders succeed.”

SETsquared Bristol members have also seen past success at The Europas, with Immersive Labs announced as finalists in 2019, and Ultraleap and Elvie both winners in 2018 and 2017 respectively.

Set up in 2009 by Mike Butcher of Techcrunch, The Europas have recognised some of Europe’s most ambitious and successful startups, including Spotify, Transferwise, Soundcloud and Babylon Health.

Recent News, Blogs and Stories

DRIFT Energy’s fleet of net positive ships (MVY – Most Valuable Yachts) - credit DRIFT Energy

DRIFT Energy plans first green hydrogen-producing vessel build following seed investment

DRIFT Energy has announced the close of its seed funding round led by Octopus Ventures, and with support from Blue Action Accelerator, the company has secured a total of £4.65...
FluoretiQ founders smiling with technology on PC

FluoretiQ patent granted to enable fast and accurate antibiotic testing

Bristol-based biotech company, FluoretiQ, who is developing fast and accurate point-of-care testing for Urinary Tract Infections (UTIs) and Sexually Transmitted Diseases (STDs), has taken a significant step forward after having...
GenomeKey blood sample in lab

GenomeKey awarded $11.4M to transform sepsis diagnosis and treatment

GenomeKey has been awarded a major grant from Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) to build a functioning, automated prototype of their desktop diagnostic device. The Bristol-based company joined our...

SUCCESS IS THE GOAL

Fast track your technology business